153108-98-6Relevant academic research and scientific papers
MYXOVIRUS THERAPEUTICS, COMPOUNDS, AND USES RELATED THERETO
-
Page/Page column 4; 26, (2013/05/21)
This disclosure relates to antiviral compounds disclosed herein and uses related thereto. In certain embodiments, the disclosure relates to pharmaceutical compositions. Typically, the pharmaceutical composition comprises a compound of formula I: Formula I
Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: Synthesis, structure-activity relationships, and pharmacokinetics
Ndungu, J. Maina,Krumm, Stefanie A.,Yan, Dan,Arrendale, Richard F.,Reddy, G. Prabhakar,Evers, Taylor,Howard, Randy,Natchus, Michael G.,Saindane, Manohar T.,Liotta, Dennis C.,Plemper, Richard K.,Snyder, James P.,Sun, Aiming
supporting information; experimental part, p. 4220 - 4230 (2012/06/30)
The measles virus (MeV), a member of the paramyxovirus family, is an important cause of pediatric morbidity and mortality worldwide. In an effort to provide therapeutic treatments for improved measles management, we previously identified a small, non-nucl
NEW BRADYKININ B1 ANTAGONISTS
-
Page/Page column 35, (2008/12/08)
The invention relates to compounds of formula (I), wherein R1 to R5 and X1 to X4, n and m have the meaning as cited in the description and the claims. Said compounds are useful as Bradykinin B1 antagonists. The
Highly stereoselective total syntheses of (+)-allopumiliotoxins 267A and 339A via intramolecular nickel(II)/chromium(II)-mediated cyclization
Aoyagi, Sakae,Wang, Tzu-Chueh,Kibayashi, Chihiro
, p. 11393 - 11409 (2007/10/02)
Remarkably high regio- and stereoselective approaches for the syntheses of dendrobatid alkaloids (+)allopumiliotoxin 267A and 339A have been develop. As a model study for these alkaloids, we initially undertook intramolecular chromium(II)-mediated cycliza
